← Back to Search

Transcranial magnetic stimulation participants for Healthy Subjects

N/A
Waitlist Available
Led By John A Westbrook, PhD
Research Sponsored by Brown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in the exponent estimated from eeg data immediately before versus immediately after target transcranial magnetic stimulation.
Awards & highlights

Study Summary

This trial tests how brain activity changes when doing hard tasks and when exposed to magnetic stimulation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in long-range temporal correlations measured immediately after, versus immediately before target transcranial magnetic stimulation.
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in long-range temporal correlations measured immediately after, versus immediately before target transcranial magnetic stimulation. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Avalanche duration statistics - dissipated effects of sham stimulation
Avalanche duration statistics - dissipated effects of target stimulation
Avalanche duration statistics - immediate effects of sham stimulation
+18 more
Secondary outcome measures
E/I balance - dissipated effects of sham stimulation
E/I balance - dissipated effects of target stimulation
E/I balance - immediate sham stimulation effects
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Transcranial magnetic stimulation participantsExperimental Treatment1 Intervention
All participants will be recruited into a single arm where, across two sessions they will receive transcranial magnetic stimulation in separate session to either the dorsolateral prefrontal cortex or the angular gyrus. Session order will be counter-balanced across participants, and stimulation target will be blinded to the participants until after their participation is complete.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
transcranial magnetic stimulation
2013
Completed Phase 2
~660

Find a Location

Who is running the clinical trial?

Brown UniversityLead Sponsor
456 Previous Clinical Trials
563,051 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,782 Previous Clinical Trials
2,689,077 Total Patients Enrolled
John A Westbrook, PhDPrincipal InvestigatorBrown University
1 Previous Clinical Trials
60 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals currently able to participate in this experiment?

"The data published on clinicaltrials.gov indicates that this trial is actively searching for patients to participate in it. It was initially posted on April 1st 2023, and the latest version of the study was up-to-date as of March 31st 2023."

Answered by AI

Does this experimental program encompass individuals older than 25 years old?

"According to the inclusion criteria, participants must range between 18 and 45 years of age. For minors, there are 54 separate trials while those over 65 can access 369 different studies."

Answered by AI

What are the eligibility requirements to participate in this research?

"To be considered eligible for this trial, aspiring participants must fit the criteria of healthy individuals aged 18-45 years old. 30 volunteers are required to complete the experiment."

Answered by AI

What is the participant pool size for this clinical examination?

"Affirmative. According to the information available on clinicaltrials.gov, recruitment for this medical study is ongoing; it was initially posted in April 1st 2023 and lastly updated on March 31st of the same year. A total of thirty individuals are needed from one site alone."

Answered by AI

What objectives does this clinical trial hope to accomplish?

"This trial's primary aims are to measure the immediate effects of target stimulation and gauge participants' functional excitation-inhibition balance (E/I Balance) 20 minutes before their first transcranial magnetic stimulation session. Secondary objectives include quantifying how prolonged target or sham stimulations impact E/I balances, with a focus on assessing any protracted recovery following either type of treatment."

Answered by AI
~14 spots leftby Apr 2025